All Posts
Review | Role of AI and digital pathology for colorectal immuno-oncology.
16 Dec, 2022 | 13:11h | UTCRole of AI and digital pathology for colorectal immuno-oncology – British Journal of Cancer
A comprehensive systematic review of colorectal cancer screening clinical practices guidelines and consensus statements.
16 Dec, 2022 | 13:09h | UTC
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022.
15 Dec, 2022 | 13:52h | UTCBHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022 – HIV Medicine
SR | Ultrasound guidance versus landmark method for peripheral venous cannulation in adults.
16 Dec, 2022 | 13:08h | UTC
Pediatric intensive care ‘do not do’ recommendations in Spain: selection by Delphi method.
15 Dec, 2022 | 13:50h | UTC
RCT | Mindfulness training and exercise did not improve cognitive function in older adults.
15 Dec, 2022 | 13:48h | UTCEffects of Mindfulness Training and Exercise on Cognitive Function in Older Adults: A Randomized Clinical Trial – JAMA (free for a limited period)
See also: Visual Abstract
News Release: Exercise, mindfulness don’t appear to boost cognitive function in older adults – Washington University School of Medicine
Guidelines for reporting outcomes in trial reports: The CONSORT-Outcomes 2022 Extension.
15 Dec, 2022 | 13:45h | UTCGuidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension – JAMA (free for a limited period)
See also: Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension – JAMA (free for a limited period)
Commentary on Twitter
This report, the Consolidated Standards of Reporting Trials (CONSORT)–Outcomes 2022 extension, is a consensus statement on standards for reporting outcomes in clinical trial reports & contains recommendations to be integrated w the CONSORT 2010 statement. https://t.co/3cMgBmHtyE
— JAMA (@JAMA_current) December 14, 2022
Guidelines for reporting outcomes in trial protocols: The SPIRIT-Outcomes 2022 Extension.
15 Dec, 2022 | 13:46h | UTCGuidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension – JAMA (free for a limited period)
See also: Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension – JAMA (free for a limited period)
Commentary on Twitter
This Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)-Outcomes 2022 extension of the SPIRIT 2013 statement provides 9 outcome-specific items that should be addressed in all trial protocols. https://t.co/OheGrTmcMh
— JAMA (@JAMA_current) December 13, 2022
Consensus Statement | Continuous glucose monitoring and metrics for clinical trials.
15 Dec, 2022 | 13:42h | UTCContinuous glucose monitoring and metrics for clinical trials: an international consensus statement – The Lancet Diabetes & Endocrinology (free registration required)
Commentary on Twitter
Online—Continuous glucose monitoring and metrics for clinical trials: an international consensus statement https://t.co/hrNXB9ycr0 #CGM #diabetes #FREE to read with registration (also FREE) #IDF2022 pic.twitter.com/x40lzAL1by
— The Lancet Diabetes & Endocrinology (@TheLancetEndo) December 7, 2022
Associations between extreme temperatures and cardiovascular cause-specific mortality: results from 27 countries.
15 Dec, 2022 | 13:44h | UTCNews Release: About 1 in 100 heart disease deaths linked to extreme hot and cold weather days – University of Maryland School of Medicine
RCT | Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson’s disease.
15 Dec, 2022 | 13:38h | UTCSafety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson’s disease: a randomised, double-blind, active-controlled, phase 3 trial – The Lancet Neurology (link to abstract – $ for full-text)
Commentary on Twitter
In a phase 3, randomised controlled trial, Michael Soileau and colleagues aimed to assess the safety and efficacy of a soluble formulation of levodopa and carbidopa in patients with advanced Parkinson's disease. Read the results at: https://t.co/9G8S01juSC pic.twitter.com/0SG0oTe8na
— The Lancet Neurology (@TheLancetNeuro) November 17, 2022
Review | Management of chronic migraine.
15 Dec, 2022 | 13:41h | UTCManagement of chronic migraine – The BMJ
Review | Management of psychiatric and cognitive complications in Parkinson’s disease.
15 Dec, 2022 | 13:39h | UTCManagement of psychiatric and cognitive complications in Parkinson’s disease – The BMJ
RCT | Comparing bupivacaine alone to liposomal bupivacaine plus bupivacaine in interscalene blocks for total shoulder arthroplasty.
15 Dec, 2022 | 13:36h | UTC
RCT | US-guided pudendal nerve block vs. US-guided penile nerve block for analgesia during pediatric circumcision.
15 Dec, 2022 | 13:31h | UTCRandomized controlled trial (RCT) comparing ultrasound-guided pudendal nerve block with ultrasound-guided penile nerve block for analgesia during pediatric circumcision – Regional Anesthesia & Pain Medicine (link to abstract – $ for full-text)
RCT | Assessment of spleen-preserving hilar lymphadenectomy for advanced proximal gastric cancer without invasion into the greater curvature.
15 Dec, 2022 | 13:30h | UTCAssessment of Laparoscopic Spleen-Preserving Hilar Lymphadenectomy for Advanced Proximal Gastric Cancer Without Invasion Into the Greater Curvature: A Randomized Clinical Trial – JAMA Surgery (link to abstract – $ for full-text)
See also: Visual Abstract and Video Summary
Post-trial follow-up | Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer.
15 Dec, 2022 | 13:29h | UTCFluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)
Commentary: Dose-Dense Adjuvant Chemotherapy “Optimal” for High-Risk Early Breast Cancer – Cancer Therapy Advisor
Commentary on Twitter
Online first: end-of-study results from the randomised, phase 3 GIM2 trial: #fluorouracil and dose-dense adjuvant #chemotherapy in patients with #early-stage #breastcancer https://t.co/9YD5w9aLY2 pic.twitter.com/RmPdi37sQB
— The Lancet Oncology (@TheLancetOncol) November 10, 2022
Review | Ultrasound imaging of bone fractures.
15 Dec, 2022 | 13:27h | UTCUltrasound imaging of bone fractures – Insights into Imaging
Pictorial Review | Nerve entrapment syndromes of the upper limb.
15 Dec, 2022 | 13:25h | UTCNerve entrapment syndromes of the upper limb: a pictorial review – Insights into Imaging
Special Report | Global burden of cardiovascular diseases and risks collaboration.
14 Dec, 2022 | 15:57h | UTCHomepage and Infographic: Global Burden of Cardiovascular Diseases and Risks Collaboration – Journal of the American College of Cardiology
News Release: New report tracks latest trends in global cardiovascular health – Institute for Health Metrics and Evaluation
Full Report: Global Burden of Cardiovascular Diseases and Risks Collaboration – Journal of the American College of Cardiology
Commentary on Twitter
🆕 Special @JACCJournals Issue Tracks Latest Trends in Global Burden of CVD
The issue looks at data addressing 18 specific CV conditions and 15 risk factors from 21 regions & 204 countries & territories. Learn more: https://t.co/w1PmJ98KrW #CardioTwitter pic.twitter.com/JCTQsr4dLK
— American College of Cardiology (@ACCinTouch) December 12, 2022
Research Opportunities in the treatment of mitral valve prolapse: JACC Expert Panel.
14 Dec, 2022 | 15:10h | UTC
Cohort Study | Association between the use of mobile devices for calming and executive functioning in children aged 3 to 5 years.
14 Dec, 2022 | 15:07h | UTCLongitudinal Associations Between Use of Mobile Devices for Calming and Emotional Reactivity and Executive Functioning in Children Aged 3 to 5 Years – JAMA Pediatrics (free for a limited period)
News Release: Frequently using digital devices to soothe young children may backfire – University of Michigan
Commentary: Giving your child a screen may hinder emotional regulation, study says. Here’s what to do instead – CNN
RCT | A calorie-unrestricted low-carbohydrate, high-fat diet resulted in short-term weight loss and better glycemic control.
14 Dec, 2022 | 15:08h | UTCEffect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentary: Low-Carbohydrate, High-Fat Diet Beneficial in T2DM in Short Term – HealthDay
Summary for Patients: Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease – Annals of Internal Medicine
Commentary on Twitter
RCT finds low-carb diet beats low-fat diet for weight loss and glucose control in patients with #type2diabetes over 6-month intervention, but changes not sustained. @AleksanderKrag @Camilla_Dalby @FLASH_OUH: https://t.co/4v58k8KK4x pic.twitter.com/zwgIBDCxCB
— Annals of Int Med (@AnnalsofIM) December 13, 2022
M-A | Predicting neurological outcome in adult patients with cardiac arrest.
14 Dec, 2022 | 15:02h | UTC
Cohort Study | Assessment of depression and adherence to guideline-directed medical therapies following PCI.
14 Dec, 2022 | 14:59h | UTCCommentaries: